S&P 500 7,376.86 +0.31%
Nasdaq 24,579.42 +1.09%
S&P/TSX 35,789.09 +0.52%
Apple 342.37 −0.52%
Nvidia 186.64 +2.78%
Microsoft 530.61 −0.99%
Shopify 210.47 +4.59%
Royal Bank 284.16 −0.59%
CAD/USD 0.7078 −0.79%
CLOSED · 05:55 ET
Market ClerkRecap
Sun Nov 8 · markets closed4 signals on Nov 7227 insider buys this week · $429.6MCIRO short report next: Nov 15The week ahead

NEOG

NEOGEN CORP
NASDAQ · HEALTH CARE · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
11.76
+0.08 +0.68%
USD · Nov 6, 06:40 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose NEOG in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
No 13D or 13G filing on NEOG in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch NEOG. Know when insiders buy.
One email the day a filing lands. Free.